Etomidate Injection, Solution
Product Images NDC 65219-447

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 65219-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eto04 0000 01)

Structural Formula (Eto04 0000 01)
Chemical structure of Etomidate, showing its molecular arrangement with an imidazole ring, ester group, and phenyl substituent. The structure illustrates key functional groups characteristic of the active ingredient Etomidate.*
FDA Label Image

Fresenius Kabi Logo (Eto04 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)
Label for Etomidate Injection, USP, 20 mg/10 mL (2 mg/mL) intravenous solution. It is a 10 mL single-dose vial labeled for prescription use only, manufactured by Fresenius Kabi USA, LLC. The label includes active ingredient concentration, inactive ingredients, storage conditions, and directions to see the package insert for dosage.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)
Packaging label for Etomidate Injection, USP, 2 mg/mL (20 mg/10 mL) solution for intravenous use. The label indicates a package containing 10 single-dose 10 mL vials. The labeler is Fresenius Kabi USA, LLC. Additional details include storage instructions, ingredients, batch overprinting area, and a barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)
Label for Etomidate Injection, USP 2 mg/mL in a 20 mL single-dose vial. The label shows a concentration of 40 mg per 20 mL, for intravenous use only. It includes contents information, storage instructions at controlled room temperature, and is manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)
The packaging label for Etomidate Injection, USP, shows a 2 mg/mL concentration with a total of 40 mg per 20 mL. It is indicated for intravenous use only and is supplied in 10 single-dose vials of 20 mL each. The labeler is Fresenius Kabi USA, LLC, and the product includes storage instructions and ingredient information. The packaging displays the NDC 65219-447-20 and has branding details with a barcode and website.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.